January 2007 - mysccg.com

4
SCCG News SENIOR CARE CONSULTANT GROUP January 2007 In this Issue: Adverse Drug Events Renal Impairment Alzheimer’s Drugs Failing Tropical Fruit Juices Skin Tears in the Elderly MedicationUpdate Rumor vs. Truth NutritionUpdate CaregivingUpdate Depression After Stroke Adverse Drug Events Adverse drug events send elderly patients to the emergency department about as often as car accidents. Over 700,000 patients are treated in emergency departments each year for adverse drug events, or 2.4 out of every 1,000. And one in six of these are hospitalized. The most common reactions are dermatologic, gastrointestinal and neurological. One- third of events are due to allergies, another third are unintentional overdoses. The most common culprits are insulins, opioids, anticoagulants, amoxicillin and antihistamines or cold remedies. Almost one-third of adverse drug events in the elderly are caused by just three drugs: warfarin, insulin and digoxin. And these drugs have been around for a long time. Keep in mind that these numbers probably underestimate how often drug reactions present to emergency departments. It is important to watch for appropriate doses. Up to half of adverse drug events may be due to too much drug for the patient’s age, weight, renal function, or diseases. Patients should stay on the look-out for significant drug interactions. As well as making sure they are not doubling up by continuing a similar drug that is supposed to be discontinued or changed. Close monitoring is recommended for patients on warfarin or insulin. Page 1 Experts are reminding us of the risk of renal impairment in patients taking an ACE inhibitor or ARB, diuretic, and NSAID. These drugs reduce renal perfusion by different mechanisms. Combining any two of these drugs can lead to acute renal failure in susceptible patients. Combining all three is a “triple whammy.” These are patients who already have impaired renal function or those at risk due to older age, heart failure, dehydration, etc. Avoiding chronic NSAIDs or aspirin for pain is recommended for these patients. However, stopping low-dose aspirin is NOT recommended; doses of 325 mg/day or less aren’t likely to cause renal problems. Monitoring susceptible patients for worsening renal function, increased blood pressure or potassium or edema is recommended. Physicians do not need to reduce the dose or stop an ACE inhibitor or ARB unless serum creatinine increases more than 30% within 2 months of starting the drug, or serum potassium exceeds 5.5 mEq/L. Consultant Pharmacists . . . Dispensing Knowledge Most Alzheimer’s patients will not benefit from the drugs most commonly used to treat their agitation and aggression, a new major has found. The drugs, Zyprexa, Seroquel and Risperdal, are no more effective than placebos, according to the study published in The New England Journal of Medicine. The drugs also put patients at risk for serious side effects. It is the third major study to find that the drugs, known as atypical antipsychotics, are not as effective as they have been portrayed. Antipsychotic Drugs Failing Renal Impairment

Transcript of January 2007 - mysccg.com

Page 1: January 2007 - mysccg.com

SCCG News�SENIOR CARE CONSULTANT GROUP�

January 2007�

In this Issue:�·� Adverse Drug�

Events�·� Renal Impairment�·� Alzheimer’s Drugs�

Failing�·� Tropical Fruit Juices�·� Skin Tears in the�

Elderly�·� MedicationUpdate�·� Rumor vs. Truth�·� NutritionUpdate�·� CaregivingUpdate�·� Depression After�

Stroke�

Adverse Drug Events�

A�dverse drug events send elderly patients to the emergency department about as�often as car accidents. Over 700,000 patients are treated in emergency departments�each year for adverse drug events, or 2.4 out of every 1,000. And one in six of these are�hospitalized.�

The most common reactions are dermatologic, gastrointestinal and neurological. One-�third of events are due to allergies, another third are unintentional overdoses. The most�common culprits are insulins, opioids, anticoagulants, amoxicillin and antihistamines or�cold remedies.�

Almost one-third of adverse drug events in the elderly are caused by just three drugs:�warfarin, insulin and digoxin. And these drugs have been around for a long time. Keep in�mind that these numbers probably underestimate how often drug reactions present to�emergency departments.�

It is important to watch for appropriate doses. Up to half of adverse drug events may be�due to too much drug for the patient’s age, weight, renal function, or diseases. Patients�should stay on the look-out for significant drug interactions. As well as making sure they�are not doubling up by continuing a similar drug that is supposed to be discontinued or�changed. Close monitoring is recommended for patients on warfarin or insulin.�

Page 1�

E�xperts are reminding us of the risk of renal impairment�in patients taking an ACE inhibitor or ARB, diuretic, and�NSAID. These drugs reduce renal perfusion by different�mechanisms. Combining any two of these drugs can lead�to acute renal failure in susceptible patients. Combining all�three is a “triple whammy.” These are patients who�already have impaired renal function or those at risk due�to older age, heart failure, dehydration, etc. Avoiding�chronic NSAIDs or aspirin for pain is recommended for�these patients. However, stopping low-dose aspirin is�NOT recommended; doses of 325 mg/day or less aren’t�likely to cause renal problems.�

Monitoring susceptible patients for worsening renal�function, increased blood pressure or potassium or edema�is recommended. Physicians do not need to reduce the�dose or stop an ACE inhibitor or ARB unless serum�creatinine increases more than 30% within 2 months of�starting the drug, or serum potassium exceeds 5.5 mEq/L.�

Consultant Pharmacists . . . Dispensing Knowledge�

M�ost Alzheimer’s patients will not benefit from�the drugs most commonly used to treat their�agitation and aggression, a new major has found.�The drugs, Zyprexa, Seroquel and Risperdal, are�no more effective than placebos, according to the�study published in�The�New England Journal of�Medicine.�

The drugs also put�patients at risk for�serious side effects. It is�the third major study to�find that the drugs,�known as atypical�antipsychotics, are not as�effective as they have�been portrayed.�

Antipsychotic Drugs Failing�Renal Impairment�

Page 2: January 2007 - mysccg.com

T�ropical fruit juices such as MonaVie, XanGo, Noni,�Gogi, and Pom Wonderful are making a big splash.�They’re promoted for everything from longevity to�infections and cancer. And the promotions are so�convincing that they sometimes can even make�pharmacists wonder if the claims are valid.�

These juices contain antioxidants. But this doesn’t�mean that they can be counted on to cure certain�diseases. And they often sell for over $40/bottle.�

Acai� (A-sigh-EE) is the main ingredient in MonaVie.�Acai is sometimes called a “superfood” because it�contains more antioxidants than blueberries or�cranberries. But there’s no proof that it’s more�beneficial than other foods.�

Mangosteen� is often called “Xango” juice. It is high in�antioxidants called xanthones.�

Mornida is also know as “Noni” juice. It MIGHT be�associated with a few cases of liver toxicity.�

Patients on ACEs, ARBs and�spironolactone should be warned�that morinda is high in potassium,�almost 15 mEq per 8 ounces.�

Goji contains sterols that prevent�cholesterol absorption, but there’s�no proof that drinking Goji helps lower cholesterol. To�be safe, patients on warfarin should stay away from�Goji as it might inhibit warfarin metabolism.�

Pomegranate juice (Pom Wonderful) has preliminary�evidence that it might have some cardiovascular�benefits. But there are concerns about possible drug�interactions, similar to grapefruit juice.�

People should remember that these are basically fruit�juices and okay to drink in modest amounts. But�despite the hype, there is no proof they cure any�disease, and people should not expect miracle cures.�

Tropical Fruit Juices Making a Big Splash�

Page 2�

P�eople over 65 experience about 90% of all skin tears, according to a recent study of nearly 3,000 incident�reports in Pennsylvania.�

While most skin tears are not serious enough to extend a hospital stay, they represent painful and unsightly�injuries, according to an article published in the September issue of the�Patient Safety Advisory�. It examined a�stud of 2,807 reports submitted by healthcare facilities to the Pennsylvania Patient Safety Reporting System�(PA-PSRS).�

Reports submitted to PA-PSRS during the system’s first full 12 months of mandatory statewide reporting reflect�findings from previous studies, which show the risk of skin tears increasing with age. The largest proportion of�skin tear reports (41%) concern patients aged 75 to 84.�

Treating a skin tear is also time consuming and painful for the patient. One report highlighted in the article�describes a patient having to undergo stapling and stitches to treat a skin-tear wound. Also, if changing the�dressing for a skin tear is done incorrectly, further injury may occur.�

“The (state’s Patient Safety) Authority chose to highlight the skin tear issue because of the high number of�patients who experience these painful wounds, especially among older and more fragile populations,” said Alan�B.K. Rabinowitz, administrator of the Patient Safety Authority. “By providing clinical guidance about prevention�and treatment of skin tears, we hope that healthcare facilities and providers will better understand the additional�risks associated with skin tears and the number of ways these injuries can be prevented.”�

Some patients characteristics cited in the� Advisory� that often mean a patient’s skin is more fragile and�susceptible to tears include: advanced age (over age 70); malnourishment; vision/sensation/hearing loss; mental�impairment; and immobility.�

The article includes several preventive measures. The Authority also is supplying healthcare facilities with a�“Skin Tears Toolkit” to help them prevent injuries. For this and other information, visit the Authority’s Web site at�www.psa.state.pa.us.�

Older People More Prone to Skin Tears�

Page 3: January 2007 - mysccg.com

I�t turns out pot could be like, good for the brain. A main ingredient in marijuana, THC, appears�to slow the progression of Alzheimer’s disease, according to a research team at the Scripps�Research Institute in La Jolla, CA.�

A� new treatment involving monthly eye injections of an antibody may help prevent blindness�associated with “wet” age-related macular degeneration, according to studies in the� New England�Journal of Medicine.�

T�reating dementia with cholinesterase inhibitors, or ChE-IS, may help delay their placement into nursing�homes, according to a study in the journal,�Alzheimer’s Disease and Associated Disorders�. The drug is also�known as Aricept, Excelon and Razadyne.�

M�anufacturer prices for the most commonly prescribed drugs for people 50 and older increased by an�average of 6.3% during the 12-month period ending in June, according to a recently released AARP survey. The�rise out-paced inflation.�

O�lder patients experience a drug error rate nearly seven times greater than younger patients, according to an�analysis by Medco Health Solutions, a prescription drug manager. Patients over 65 faced the greatest risk of�errors.�

Page 3�

Medication�Update�

Rumor vs. Truth�

R�umor: Vitamin D helps prevent some cancers.�

T�ruth: Vitamin D deficiency is associated with an increased risk of breast, colon,�prostate, pancreatic and ovarian cancer. Researchers think vitamin D might have�

antiproliferative effects in these cancers. Recent research seems to support this hypothesis. Higher vitamin D�serum levels seem to be associated with a reduced risk of cancer and cancer-related mortality in men. And�people with higher intakes of vitamin D appear to have a lower risk for pancreatic cancer.�

Patients should understand that this is interesting research, but it's too soon to say that taking vitamin D�supplements will prevent cancer. But it's another good reason to ensure that they get enough vitamin D through�dietary measures and sun exposure.�

The best source of vitamin D comes from the sun. Ultraviolet-B light stimulates vitamin D synthesis in the skin,�providing as much as 80% to 90% of the body's vitamin D stores. This is why vitamin D deficiency is most�common in the northern latitudes, including Canada and the northern US where people are exposed to less sun.�Prevalence of vitamin D deficiency is on the rise, possibly due to overzealous use of sunscreens.�

Patients need to be reassured that BRIEF periods of unprotected sun exposure is not harmful. And just 15�minutes of sun exposure 2 to 3 times a week, is probably enough to meet Vitamin D needs for fair-skinned�people. Darker-skinned people or those at more northern latitudes might need more. For longer exposure,�recommend use of a sunscreen with an SPF 15 or greater to protect the skin.�

Patients who have minimal exposure to the sun are advised to get at least 400 IU/day of vitamin D from diet or�supplements, while 800 IU/day for elderly patients is recommended to help prevent osteoporosis.�

Page 4: January 2007 - mysccg.com

Page 4�

P�eople are asking about the benefits of green tea. Lots of green tea drinks are hitting�the market, plus a new population study suggests that green tea decreases mortality.�

Green tea is high in polyphenols, substances which act as free-radical scavengers and�antioxidants. So far, most of the attention has been on green tea. But black and oolong�tea also contain similar amounts of polyphenols. Polyphenols are also found in virgin�olive oil, chocolate, red wine, and other foods thought to have extra health benefits.�

Cardiovascular - Epidemiologic studies suggest that people who drink green tea have a�lower risk of hypertension and heart disease. Now an observational study from Japan�suggests that people who drink green tea are less likely to die of cardiovascular disease. But this is seen in people�who drink 3 to 5 cups/day or more, and it doesn’t prove that green tea is responsible for the benefit.�

Cancer - Numerous studies show an association between consuming green tea and a decrease in different types of�cancer. But patients should know that there’s no proof that green tea prevents cancer.�

Weight loss - A new green tea soft drink called�Enviga� is being introduced by Coca-Cola. They claim it helps burn�calories, about 20 to 33 calories per 12-ounce can.�Enviga� also contains 100 mg of caffeine, 3 times as much as�Coke�.�Green tea and caffeine can help boost metabolism. But people should not count on�Enviga� for significant weight loss.�

Diabetes - people who drink a lot of green tea or coffee seem to have a lower risk of developing type 2 diabetes. Coffee�also contains polyphenols, or the caffeine might play a role.�

It’s too soon to tell if tea has any long-term benefits. People should be advised not to get carried away and consume�too much caffeine.�

Nutrition�Update�

S�troke survivors, their families and their physicians should be on the�lookout for depression, even years after an incident occurs, a new study�suggests. Many long-term survivors suffer from this problem but few�actually receive treatment, according to a report in the journal�Stroke�.�

Investigators from the National Stroke Research Institute in Victoria,�Australia, identified depression in 17% of a group of 289 five-year�stroke survivors. Only 22% of that subgroup were taking an�antidepressant medication.�

Depression After Stroke�

Caregiving�Update�

F�lex those muscles, arthritis sufferers. That’s the advice from a new study that indicates strength training for the legs�may slow knee arthritis. Researchers found that older adults with knee osteoarthritis who underwent lower-body�strength training showed less narrowing in the knee joint space over more than two years, an indication that their�arthritis was progressing more slowly.�

S�eniors who received two small doses of behavioral therapy two weeks apart recorded notable improvement in�sleep-quality measurers, compared with peers who only received information on insomnia, researchers at the�University of Pittsburgh School of Medicine found. Nearly twice as many of those behavioral therapy study subjects�(71% to 39%) slept better and also noted significant improvement in daytime symptoms of depression and anxiety,�according to the study.�

T�he incidence of Alzheimer’s disease in older people who drank fruit or vegetable juices three or more times a week�was 76% lower than those who did not, a 10-year study showed. It was 16% lower in those who drank juice once or�twice a week, according to researchers at Vanderbilt University School of Medicine. Researchers attributed the positive�effect to polyphenols, a strong antioxidant found in the peel of skins of fruits and vegetables.�